Holen Sie sich die Stockscreener-App
95.15
0.82%
0.77
Handel nachbörslich:
95.15
Schlusskurs vom Vortag:
$94.38
Offen:
$94.5
24-Stunden-Volumen:
109.25K
Relative Volume:
0.69
Marktkapitalisierung:
$2.15B
Einnahmen:
$213.03M
Nettoeinkommen (Verlust:
$41.32M
KGV:
51.99
EPS:
1.83
Netto-Cashflow:
$33.49M
1W Leistung:
+2.06%
1M Leistung:
+13.70%
6M Leistung:
-1.90%
1J Leistung:
+14.90%
1-Tages-Spanne:
$94.42
$96.12
1-Wochen-Bereich:
$90.93
$96.12
52-Wochen-Spanne:
$71.42
$109.58
Lemaitre Vascular Inc Stock (LMAT) Company Profile
Firmenname
Lemaitre Vascular Inc
Sektor
Telefon
781-221-2266
Adresse
63 SECOND AVENUE, BURLINGTON, MA
Vergleichen Sie LMAT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LMAT
Lemaitre Vascular Inc
|
95.15 | 2.14B | 213.03M | 41.32M | 33.49M | 1.83 |
|
ISRG
Intuitive Surgical Inc
|
482.35 | 171.42B | 9.15B | 2.63B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
195.96 | 55.88B | 21.39B | 1.61B | 2.55B | 5.56 |
|
ALC
Alcon Inc
|
86.48 | 42.55B | 9.93B | 1.12B | 1.43B | 2.26 |
|
RMD
Resmed Inc
|
288.28 | 41.48B | 5.15B | 1.40B | 1.65B | 9.51 |
|
WST
West Pharmaceutical Services Inc
|
246.22 | 17.25B | 2.90B | 467.20M | 306.90M | 6.37 |
Lemaitre Vascular Inc Stock (LMAT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-06 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2025-02-28 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2025-02-28 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2025-02-13 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-10-15 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2024-08-02 | Fortgesetzt | Lake Street | Buy |
| 2024-05-31 | Fortgesetzt | ROTH MKM | Buy |
| 2024-04-26 | Hochstufung | Stifel | Hold → Buy |
| 2024-02-06 | Fortgesetzt | KeyBanc Capital Markets | Sector Weight |
| 2023-10-23 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-09-06 | Eingeleitet | Oppenheimer | Outperform |
| 2023-08-03 | Herabstufung | Jefferies | Buy → Hold |
| 2023-05-03 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2022-10-28 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2021-09-16 | Eingeleitet | Jefferies | Buy |
| 2021-02-12 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-03-16 | Hochstufung | Sidoti | Neutral → Buy |
| 2019-10-24 | Herabstufung | First Analysis Sec | Strong Buy → Outperform |
| 2019-10-24 | Hochstufung | Lake Street | Hold → Buy |
| 2019-10-14 | Hochstufung | First Analysis Sec | Outperform → Strong Buy |
| 2019-07-25 | Bestätigt | Barrington Research | Outperform |
| 2019-07-25 | Hochstufung | First Analysis Sec | Neutral → Outperform |
| 2018-10-08 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2018-10-08 | Hochstufung | ROTH Capital | Neutral → Buy |
| 2018-06-08 | Fortgesetzt | ROTH Capital | Buy |
| 2018-04-26 | Herabstufung | Stifel | Buy → Hold |
| 2018-04-26 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2017-10-27 | Herabstufung | First Analysis Sec | Overweight → Equal-Weight |
| 2017-10-27 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2017-07-10 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2017-07-10 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2017-03-21 | Eingeleitet | First Analysis Sec | Overweight |
| 2017-02-22 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2016-09-22 | Herabstufung | Sidoti | Buy → Neutral |
| 2016-07-28 | Bestätigt | Barrington Research | Outperform |
| 2016-02-25 | Bestätigt | Barrington Research | Outperform |
Alle ansehen
Lemaitre Vascular Inc Aktie (LMAT) Neueste Nachrichten
Lemaitre Vascular director Roush sells $695k in LMAT stock - Investing.com
LeMaitre Vascular director Ross sells $235k in shares - Investing.com
Barrington Research Has Positive Outlook of LMAT Q3 Earnings - MarketBeat
Roth Capital Forecasts Higher Earnings for LeMaitre Vascular - MarketBeat
Can LeMaitre Vascular (LMAT) Balance Consistent Dividends With Sustained Earnings Growth? - simplywall.st
LMAT Q2 Deep Dive: International Expansion and Product Momentum Drive Upbeat Outlook - ca.finance.yahoo.com
LeMaitre Vascular Inc. Recovery Hinges on Volume BreakoutStock Market Watch With Alerts Shows Unusual Activity - 선데이타임즈
LeMaitre Vascular, Inc. (NASDAQ:LMAT) CEO Sells $9,351,000.00 in Stock - MarketBeat
Can LeMaitre Vascular Inc. outperform in the next rallyUndervalued High Return Candidates - newsyoung.net
Can volume confirm reversal in LeMaitre Vascular Inc.Investment Timeline and ROI Summary Report - Newser
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Sold by Townsquare Capital LLC - MarketBeat
Roth Capital Lifts Earnings Estimates for LeMaitre Vascular - MarketBeat
LeMaitre (LMAT) is an Incredible Growth Stock: 3 Reasons Why - Yahoo Finance
LeMaitre Vascular stock holds Neutral rating at Cantor after strong Q2 - Investing.com Nigeria
LeMaitre Vascular, Inc. to Issue Quarterly Dividend of $0.20 (NASDAQ:LMAT) - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Shares Gap Up After Earnings Beat - MarketBeat
Cantor Fitzgerald Issues Positive Forecast for LeMaitre Vascular (NASDAQ:LMAT) Stock Price - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Rating Increased to Outperform at Barrington Research - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Announces Earnings Results, Beats Expectations By $0.03 EPS - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Issues Q3 2025 Earnings Guidance - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Issues FY 2025 Earnings Guidance - MarketBeat
LeMaitre Vascular Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Lemaitre Vascular Insider Sales: Signal of Caution or Strategic Wealth Management? - AInvest
LeMaitre Vascular To Go Ex-Dividend On August 21st, 2025 With 0.2 USD Dividend Per Share - 富途牛牛
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q2 2025 Earnings Call Transcript - Insider Monkey
LeMaitre Vascular’s Earnings Call Highlights Growth - TipRanks
LeMaitre Vascular Beats Expectations With Strong Sales And Profits - Finimize
Why LeMaitre (LMAT) Stock Is Trading Up Today - TradingView
LeMaitre Vascular Breaks Above 200-Day Moving AverageBullish for LMAT - Nasdaq
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Could Be 25% Above Their Intrinsic Value Estimate - simplywall.st
LEMAITRE VASCULAR INC SEC 10-Q Report - TradingView
LeMaitre (LMAT) Q2 Revenue Jumps 15% - sharewise.com
LeMaitre Vascular Reports Impressive Q2 2025 Financial ResultsNews and Statistics - IndexBox
LeMaitre Vascular Q2 Earnings, Revenue Rise; Raises 2025 Guidance - MarketScreener
LeMaitre raises 2025 revenue guidance to $251M with 15% organic growth as international launches accelerate - MSN
LeMaitre: Q2 Earnings Snapshot - New Haven Register
LeMaitre Vascular Inc (LMAT) Q2 2025 Earnings Call Highlights: Strong Sales Growth and ... - Yahoo Finance
LeMaitre Vascular Inc (LMAT) Q2 2025 Earnings Call Highlights: S - GuruFocus
LeMaitre Vascular Inc (LMAT) Q2 2025 Earnings Call Highlights: Strong Sales Growth and ... By GuruFocus - Investing.com Canada
LeMaitre (LMAT) Q2 Revenue Jumps 15% - The Motley Fool
LeMaitre Vascular's Q2 2025 Earnings Call: Unpacking Key Contradictions in Sales Growth, Pricing Strategies, and Market Opportunities - AInvest
Finanzdaten der Lemaitre Vascular Inc-Aktie (LMAT)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):